Published 21 March 2005. doi:10.1084/jem.20041393
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 201, Number 6, 925-935
Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis
Amir Abdollahi1,5,
Minglun Li1,5,
Gong Ping1,5,
Christian Plathow2,
Sophie Domhan1,5,
Fabian Kiessling2,
Leslie B. Lee4,
Gerald McMahon4,
Hermann-Josef Gröne3,
Kenneth E. Lipson4, and
Peter E. Huber1,5
1 Department of Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany
2 Diagnostic Radiology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany
3 Molecular Pathology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany
4 SUGEN, Inc., South San Francisco, CA 94080
5 Department of Radiation Oncology, University of Heidelberg Medical School, Heidelberg 69120, Germany
CORRESPONDENCE Peter Huber: p.huber{at}dkfz.de
Pulmonary fibrosis is the consequence of a variety of diseases with no satisfying treatment option. Therapy-induced fibrosis also limits the efficacy of chemotherapy and radiotherapy in numerous cancers. Here, we studied the potential of platelet-derived growth factor (PDGF) receptor tyrosine kinase inhibitors (RTKIs) to attenuate radiation-induced pulmonary fibrosis. Thoraces of C57BL/6 mice were irradiated (20 Gy), and mice were treated with three distinct PDGF RTKIs (SU9518, SU11657, or Imatinib). Irradiation was found to induce severe lung fibrosis resulting in dramatically reduced mouse survival. Treatment with PDGF RTKIs markedly attenuated the development of pulmonary fibrosis in excellent correlation with clinical, histological, and computed tomography results. Importantly, RTKIs also prolonged the life span of irradiated mice. We found that radiation up-regulated expression of PDGF (AD) isoforms leading to phosphorylation of PDGF receptor, which was strongly inhibited by RTKIs. Our findings suggest a pivotal role of PDGF signaling in the pathogenesis of pulmonary fibrosis and indicate that inhibition of fibrogenesis, rather than inflammation, is critical to antifibrotic treatment. This study points the way to a potential new approach for treating idiopathic or therapy-related forms of lung fibrosis.
Abbreviations used: CT, computed tomography; HLMVEC, human lung microvascular endothelial cell; HU, hounsfield units; HUVEC, human umbilical vein endothelial cell; IP, immunoprecipitation; IPF, idiopathic pulmonary fibrosis; IP-western, IP Western blotting; PDGF, platelet-derived growth factor; RT, radiation; RTKI, receptor tyrosine kinase inhibitor.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Strieter, R. M., Mehrad, B.
(2009). New Mechanisms of Pulmonary Fibrosis. Chest
136: 1364-1370
[Abstract]
[Full Text]
-
Korfhagen, T. R., Le Cras, T. D., Davidson, C. R., Schmidt, S. M., Ikegami, M., Whitsett, J. A., Hardie, W. D.
(2009). Rapamycin Prevents Transforming Growth Factor-{alpha}-Induced Pulmonary Fibrosis. Am. J. Respir. Cell Mol. Bio.
41: 562-572
[Abstract]
[Full Text]
-
Strieter, R. M., Keeley, E. C., Hughes, M. A., Burdick, M. D., Mehrad, B.
(2009). The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis. J. Leukoc. Biol.
86: 1111-1118
[Abstract]
[Full Text]
-
Olivieri, A., Cimminiello, M., Locatelli, F.
(2009). Response: Imatinib in lung cGVHD of mild to moderate severity. Blood
114: 3719-3720
[Full Text]
-
Huang, P., Zhao, X. S., Fields, M., Ransohoff, R. M., Zhou, L.
(2009). Imatinib attenuates skeletal muscle dystrophy in mdx mice. FASEB J.
23: 2539-2548
[Abstract]
[Full Text]
-
Olivieri, A., Locatelli, F., Zecca, M., Sanna, A., Cimminiello, M., Raimondi, R., Gini, G., Mordini, N., Balduzzi, A., Leoni, P., Gabrielli, A., Bacigalupo, A.
(2009). Imatinib for refractory chronic graft-versus-host disease with fibrotic features. Blood
114: 709-718
[Abstract]
[Full Text]
-
Hardie, W. D., Glasser, S. W., Hagood, J. S.
(2009). Emerging Concepts in the Pathogenesis of Lung Fibrosis. Am. J. Pathol.
175: 3-16
[Abstract]
[Full Text]
-
Distler, J. H. W., Distler, O.
(2009). Imatinib as a novel therapeutic approach for fibrotic disorders. Rheumatology (Oxford)
48: 2-4
[Full Text]
-
Sabnani, I., Zucker, M. J., Rosenstein, E. D., Baran, D. A., Arroyo, L. H., Tsang, P., Zubair, M., Rivera, V.
(2009). A novel therapeutic approach to the treatment of scleroderma-associated pulmonary complications: safety and efficacy of combination therapy with imatinib and cyclophosphamide. Rheumatology (Oxford)
48: 49-52
[Abstract]
[Full Text]
-
Akhmetshina, A., Dees, C., Pileckyte, M., Maurer, B., Axmann, R., Jungel, A., Zwerina, J., Gay, S., Schett, G., Distler, O., Distler, J. H. W.
(2008). Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis. FASEB J.
22: 2214-2222
[Abstract]
[Full Text]
-
Leipner, C., Grun, K., Muller, A., Buchdunger, E., Borsi, L., Kosmehl, H., Berndt, A., Janik, T., Uecker, A., Kiehntopf, M., Bohmer, F.-D.
(2008). Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis. Cardiovasc Res
79: 118-126
[Abstract]
[Full Text]
-
Andrae, J., Gallini, R., Betsholtz, C.
(2008). Role of platelet-derived growth factors in physiology and medicine. Genes Dev.
22: 1276-1312
[Abstract]
[Full Text]
-
Rogliani, P., Mura, M., Assunta Porretta, M., Saltini, C.
(2008). Review: New perspectives in the treatment of idiopathic pulmonary fibrosis. Ther Adv Respir Dis
2: 75-93
[Abstract]
-
Timke, C., Zieher, H., Roth, A., Hauser, K., Lipson, K. E., Weber, K. J., Debus, J., Abdollahi, A., Huber, P. E.
(2008). Combination of Vascular Endothelial Growth Factor Receptor/Platelet-Derived Growth Factor Receptor Inhibition Markedly Improves Radiation Tumor Therapy. Clin. Cancer Res.
14: 2210-2219
[Abstract]
[Full Text]
-
Puthawala, K., Hadjiangelis, N., Jacoby, S. C., Bayongan, E., Zhao, Z., Yang, Z., Devitt, M. L., Horan, G. S., Weinreb, P. H., Lukashev, M. E., Violette, S. M., Grant, K. S., Colarossi, C., Formenti, S. C., Munger, J. S.
(2008). Inhibition of Integrin {alpha}v 6, an Activator of Latent Transforming Growth Factor- , Prevents Radiation-induced Lung Fibrosis. Am. J. Respir. Crit. Care Med.
177: 82-90
[Abstract]
[Full Text]
-
Azuma, M., Nishioka, Y., Aono, Y., Inayama, M., Makino, H., Kishi, J., Shono, M., Kinoshita, K., Uehara, H., Ogushi, F., Izumi, K., Sone, S.
(2007). Role of {alpha}1-Acid Glycoprotein in Therapeutic Antifibrotic Effects of Imatinib with Macrolides in Mice. Am. J. Respir. Crit. Care Med.
176: 1243-1250
[Abstract]
[Full Text]
-
Okazaki, M., Gelman, A. E., Tietjens, J. R., Ibricevic, A., Kornfeld, C. G., Huang, H. J., Richardson, S. B., Lai, J., Garbow, J. R., Patterson, G. A., Krupnick, A. S., Brody, S. L., Kreisel, D.
(2007). Maintenance of Airway Epithelium in Acutely Rejected Orthotopic Vascularized Mouse Lung Transplants. Am. J. Respir. Cell Mol. Bio.
37: 625-630
[Abstract]
[Full Text]
-
Bedke, J., Kiss, E., Behnes, C.-L., Popovic, Z. V., Heuser, M., Stojanovic, T., Sijmonsma, T., Huber, P., Domhan, S., Muschal, S., Abdollahi, A., Gretz, N., Grone, H.-J.
(2007). Anti-Inflammatory Effects of {alpha}v Integrin Antagonism in Acute Kidney Allograft Rejection. Am. J. Pathol.
171: 1127-1139
[Abstract]
[Full Text]
-
Abdollahi, A., Schwager, C., Kleeff, J., Esposito, I., Domhan, S., Peschke, P., Hauser, K., Hahnfeldt, P., Hlatky, L., Debus, J., Peters, J. M., Friess, H., Folkman, J., Huber, P. E.
(2007). Transcriptional network governing the angiogenic switch in human pancreatic cancer. Proc. Natl. Acad. Sci. USA
104: 12890-12895
[Abstract]
[Full Text]
-
Leung, L. Y., Tian, D., Brangwynne, C. P., Weitz, D. A., Tschumperlin, D. J.
(2007). A new microrheometric approach reveals individual and cooperative roles for TGF-{beta}1 and IL-1{beta} in fibroblast-mediated stiffening of collagen gels. FASEB J.
21: 2064-2073
[Abstract]
[Full Text]
-
Chaudhary, N. I., Roth, G. J., Hilberg, F., Muller-Quernheim, J., Prasse, A., Zissel, G., Schnapp, A., Park, J. E.
(2007). Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis. Eur Respir J
29: 976-985
[Abstract]
[Full Text]
-
Boor, P., Konieczny, A., Villa, L., Kunter, U., van Roeyen, C. R.C., LaRochelle, W. J., Smithson, G., Arrol, S., Ostendorf, T., Floege, J.
(2007). PDGF-D inhibition by CR002 ameliorates tubulointerstitial fibrosis following experimental glomerulonephritis. Nephrol Dial Transplant
22: 1323-1331
[Abstract]
[Full Text]
-
Churg, A., Tai, H., Coulthard, T., Wang, R., Wright, J. L.
(2006). Cigarette Smoke Drives Small Airway Remodeling by Induction of Growth Factors in the Airway Wall. Am. J. Respir. Crit. Care Med.
174: 1327-1334
[Abstract]
[Full Text]
-
Tabata, C., Kadokawa, Y., Tabata, R., Takahashi, M., Okoshi, K., Sakai, Y., Mishima, M., Kubo, H.
(2006). All-trans-Retinoic Acid Prevents Radiation- or Bleomycin-induced Pulmonary Fibrosis. Am. J. Respir. Crit. Care Med.
174: 1352-1360
[Abstract]
[Full Text]
-
Zymek, P., Bujak, M., Chatila, K., Cieslak, A., Thakker, G., Entman, M. L., Frangogiannis, N. G.
(2006). The Role of Platelet-Derived Growth Factor Signaling in Healing Myocardial Infarcts. J Am Coll Cardiol
48: 2315-2323
[Abstract]
[Full Text]
-
Rajkumar, V. S., Shiwen, X., Bostrom, M., Leoni, P., Muddle, J., Ivarsson, M., Gerdin, B., Denton, C. P., Bou-Gharios, G., Black, C. M., Abraham, D. J.
(2006). Platelet-Derived Growth Factor-{beta} Receptor Activation Is Essential for Fibroblast and Pericyte Recruitment during Cutaneous Wound Healing. Am. J. Pathol.
169: 2254-2265
[Abstract]
[Full Text]
-
Ishii, Y., Fujimoto, S., Fukuda, T.
(2006). Gefitinib Prevents Bleomycin-induced Lung Fibrosis in Mice. Am. J. Respir. Crit. Care Med.
174: 550-556
[Abstract]
[Full Text]
-
Martinez, F. J., Keane, M. P.
(2006). Update in diffuse parenchymal lung diseases 2005.. Am. J. Respir. Crit. Care Med.
173: 1066-1071
[Full Text]
-
Agostini, C., Gurrieri, C.
(2006). Chemokine/Cytokine cocktail in idiopathic pulmonary fibrosis.. Proc Am Thorac Soc
3: 357-363
[Abstract]
[Full Text]
-
Ask, K., Martin, G. E. M., Kolb, M., Gauldie, J.
(2006). Targeting genes for treatment in idiopathic pulmonary fibrosis: challenges and opportunities, promises and pitfalls.. Proc Am Thorac Soc
3: 389-393
[Abstract]
[Full Text]
-
Abdollahi, A., Griggs, D. W., Zieher, H., Roth, A., Lipson, K. E., Saffrich, R., Grone, H.-J., Hallahan, D. E., Reisfeld, R. A., Debus, J., Niethammer, A. G., Huber, P. E.
(2005). Inhibition of {alpha}v{beta}3 Integrin Survival Signaling Enhances Antiangiogenic and Antitumor Effects of Radiotherapy. Clin. Cancer Res.
11: 6270-6279
[Abstract]
[Full Text]